Namzaric

Namzaric (donepezil/memantine) is an expensive drug used to treat dementia caused by Alzheimer's disease. It is more popular than comparable drugs.There are currently no generic alternatives for Namzaric. The most common version of Namzaric is covered by 75% of insurance plans at a co-pay of $50.00-$67.50, however, some pharmacy coupons or cash prices may be lower.

With the Patient Assistance Program from AbbVie, you can receive up to 12 months of medication at no cost to you if you are approved. You can also reapply as needed.